Melatonin can be injected intravenously, but only in controlled medical settings as part of clinical research or critical care treatment. There is no FDA-approved injectable melatonin product available to consumers. The oral supplements sold over the counter are the standard form, and injecting them yourself carries serious, potentially life-threatening risks.
How Injectable Melatonin Is Used in Hospitals
Intravenous melatonin has been studied in intensive care units for patients with severe sepsis, a dangerous whole-body response to infection. In one clinical trial, ICU patients received 60 mg of melatonin dissolved in a dextrose solution, delivered as a continuous IV drip over 30 minutes each day for five days. That dose is dramatically higher than the 0.5 to 5 mg found in typical sleep supplements, and it was administered under constant medical supervision with sterile pharmaceutical-grade materials.
These clinical applications are experimental. Researchers are exploring whether high-dose IV melatonin can reduce inflammation and oxidative damage in critically ill patients. This is not something prescribed for sleep problems or available at a pharmacy.
Why IV Melatonin Hits So Much Harder
The difference between swallowing melatonin and injecting it is enormous. When you take a pill, your liver breaks down most of the melatonin before it ever reaches your bloodstream. A pharmacokinetics study in healthy volunteers found that oral melatonin produced peak blood levels around 3,550 picograms per milliliter. The same dose given intravenously produced peak levels near 390,000 picograms per milliliter, roughly 100 times higher.
Oral melatonin also takes about 41 minutes to reach its peak concentration and clears from the body with a half-life of about 54 minutes. IV melatonin peaks almost immediately and has a slightly shorter half-life of around 39 minutes, meaning it floods the system fast and hard. This is useful when doctors need precise control over dosing in a critical care scenario. For sleep, it’s wildly unnecessary.
The Dangers of Self-Injection
At least one published case report documents what happens when someone injects melatonin outside a medical setting. A patient who dissolved oral melatonin tablets and injected them intravenously developed recurrent aortic valve endocarditis, a serious infection of the heart valves. He also suffered a stroke, likely caused by tablet filler material entering his bloodstream and traveling through an existing blood vessel malformation in his lungs.
The endocarditis was not caused by the melatonin itself. It resulted from injecting a non-sterile solution with a non-sterile technique. Oral tablets contain binders, fillers, coatings, and other inactive ingredients designed to be digested, not injected. When those particles enter the bloodstream directly, they can lodge in blood vessels, trigger clots, cause infections, or damage heart valves. The patient in this case also described an initial euphoric effect from the injection, which contributed to repeated use.
Any substance injected intravenously without sterile preparation and proper technique carries risks of bloodstream infections, air embolism, vein damage, and organ injury. These risks exist regardless of how safe the substance itself might be when taken by mouth.
How Injectable Melatonin Is Legally Sourced
There is no commercially manufactured, FDA-approved injectable melatonin product. When hospitals use it in clinical trials, the melatonin is prepared by compounding pharmacies under strict regulatory frameworks. Under Section 503A of federal law, compounding pharmacies can prepare patient-specific formulations only with a valid prescription for an identified individual. Larger outsourcing facilities operating under Section 503B can produce compounded drugs without patient-specific prescriptions but must follow current good manufacturing practices.
Compounded drugs, including compounded melatonin in any form, are not reviewed by the FDA for safety, efficacy, or manufacturing quality before they reach patients. Melatonin was added to the approved list of bulk substances that compounding pharmacies can work with in 2021, but this applies primarily to oral formulations for specific populations like children with autism spectrum disorder. Getting injectable melatonin prepared requires a physician’s order and a compounding facility willing and able to produce a sterile formulation.
Why Oral Melatonin Works Fine for Sleep
The low bioavailability of oral melatonin is often framed as a limitation, but for sleep support it’s actually well matched to what your body needs. Your pineal gland naturally produces melatonin in small amounts as a timing signal to prepare for sleep. Even with the liver filtering out a large percentage of an oral dose, a 0.5 to 3 mg tablet delivers enough to shift your sleep-wake cycle. Higher doses don’t necessarily produce better sleep and can cause next-day grogginess.
If oral melatonin isn’t working for you, the issue is more likely timing, dose, or an underlying sleep problem than a bioavailability problem. Taking it 30 to 60 minutes before your target bedtime, at the lowest effective dose, is the approach supported by the most evidence. Sublingual tablets that dissolve under the tongue can slightly speed absorption if you want a faster onset without the risks of injection.